Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
Phase 1
1(25.0%)
N/A
1(25.0%)
4Total
Phase 4(2)
Phase 1(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05186129Phase 1Completed

Bioequivalence Study of Clopid® (Clopidogrel) 75 mg Tablet and Plavix® 75 mg Tablet After Oral Administration to Healthy Adult Subjects Under Fasting Condition

Role: collaborator

NCT02094092Not ApplicableUnknown

Role of ProTectis on Infant Colic and Its Effect on Infant Crying Time and Maternal Mental Health

Role: lead

NCT01397994Phase 4Unknown

Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.

Role: lead

NCT00369694Phase 4Completed

Short Course Terlipressin for Control of Acute Variceal Bleeding

Role: collaborator

All 4 trials loaded